高风险-话题@MedSci

#高风险#

239篇内容 | 2087人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1862039, encodeId=285c186203961, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=Circulation：CD16依赖性自然杀伤细胞活化的遗传学和功能性分析可以识别心脏同种异体移植物脉管病的高风险患者, objectType=article, longId=118690, objectId=2dce11869033, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2dce11869033, replyNumber=0, likeNumber=61, createdTime=2017-11-06, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2dce11869033, moduleTitle=Circulation：CD16依赖性自然杀伤细胞活化的遗传学和功能性分析可以识别心脏同种异体移植物脉管病的高风险患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2dce11869033)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862018, encodeId=e89b1862018c1, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=SCI REP：ADAMTS-7与人类动脉粥样硬化中的高风险斑块表型有关, objectType=article, longId=102449, objectId=403210244971, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=403210244971, replyNumber=0, likeNumber=132, createdTime=2018-02-27, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=403210244971, moduleTitle=SCI REP：ADAMTS-7与人类动脉粥样硬化中的高风险斑块表型有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=403210244971)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862025, encodeId=5cd1186202598, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=Int J Clin Oncol：根治性前列腺切除术后接受新辅助化学激素疗法高风险前列腺癌病人的总生存率研究, objectType=article, longId=106302, objectId=149d106302b5, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=149d106302b5, replyNumber=0, likeNumber=64, createdTime=2018-06-24, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=149d106302b5, moduleTitle=Int J Clin Oncol：根治性前列腺切除术后接受新辅助化学激素疗法高风险前列腺癌病人的总生存率研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=149d106302b5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862052, encodeId=0234186205245, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=J Diabetes Complications：2型糖尿病患者中，高丙氨酸氨基转移酶水平患者的临床表型与高风险的NAFLD纤维化评分患者的临床表型不同, objectType=article, longId=129239, objectId=0cdf129239ee, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=0cdf129239ee, replyNumber=0, likeNumber=0, createdTime=2018-10-12, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=0cdf129239ee, moduleTitle=J Diabetes Complications：2型糖尿病患者中，高丙氨酸氨基转移酶水平患者的临床表型与高风险的NAFLD纤维化评分患者的临床表型不同, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=0cdf129239ee)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862026, encodeId=3b3618620265d, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=Eur Uro：中/高风险局限性前列腺癌最终治疗的种族差异：设施特征和社会经济特征的影响。, objectType=article, longId=107681, objectId=2e3010e68104, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=2e3010e68104, replyNumber=0, likeNumber=63, createdTime=2018-01-16, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=2e3010e68104, moduleTitle=Eur Uro：中/高风险局限性前列腺癌最终治疗的种族差异：设施特征和社会经济特征的影响。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=2e3010e68104)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862022, encodeId=7b06186202267, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=CLIN CANCER RES ：miRNA-DNMT1轴与与阿扎胞苷抵抗及预测高风险骨髓增生异常综合征和低原始细胞急性髓系白血病预后有关, objectType=article, longId=104465, objectId=b6041044659f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6041044659f, replyNumber=0, likeNumber=62, createdTime=2017-09-17, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6041044659f, moduleTitle=CLIN CANCER RES ：miRNA-DNMT1轴与与阿扎胞苷抵抗及预测高风险骨髓增生异常综合征和低原始细胞急性髓系白血病预后有关, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=b6041044659f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862031, encodeId=d94f186203103, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=JAMA：钠尿肽指导治疗策略对心衰高风险患者的临床意义, objectType=article, longId=110945, objectId=d06011094572, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d06011094572, replyNumber=0, likeNumber=62, createdTime=2018-04-26, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d06011094572, moduleTitle=JAMA：钠尿肽指导治疗策略对心衰高风险患者的临床意义, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d06011094572)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862045, encodeId=2260186204523, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=JAMA N：卒中二级预防，吡格列酮对高风险者更加有效, objectType=article, longId=122640, objectId=c097122640e2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c097122640e2, replyNumber=0, likeNumber=0, createdTime=2018-04-30, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c097122640e2, moduleTitle=JAMA N：卒中二级预防，吡格列酮对高风险者更加有效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c097122640e2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862047, encodeId=fffd186204e3a, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=Eur Heart J：多学科讨论：ACC/AHA极高风险标准分辨心血管病复发的能力如何？, objectType=article, longId=124753, objectId=a7f9124e5336, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a7f9124e5336, replyNumber=0, likeNumber=54, createdTime=2018-07-06, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a7f9124e5336, moduleTitle=Eur Heart J：多学科讨论：ACC/AHA极高风险标准分辨心血管病复发的能力如何？, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a7f9124e5336)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862051, encodeId=34721862051e1, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=ANN ONCOL：10年随访结果表明高风险原发乳腺癌患者接受剂量密集化疗生存情况优于常规化疗, objectType=article, longId=127759, objectId=1cf312e759fd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=1cf312e759fd, replyNumber=0, likeNumber=63, createdTime=2018-08-12, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=1cf312e759fd, moduleTitle=ANN ONCOL：10年随访结果表明高风险原发乳腺癌患者接受剂量密集化疗生存情况优于常规化疗, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1cf312e759fd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862013, encodeId=1d1f186201375, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=CLIN CANCER RES：依鲁替尼联合利妥昔单抗治疗高风险慢性淋巴细胞性白血病, objectType=article, longId=97949, objectId=75999e94942, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=75999e94942, replyNumber=0, likeNumber=69, createdTime=2017-08-07, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=75999e94942, moduleTitle=CLIN CANCER RES：依鲁替尼联合利妥昔单抗治疗高风险慢性淋巴细胞性白血病, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=75999e94942)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862040, encodeId=d5231862040b2, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=J Thromb Haemost：心血管疾病高风险患者慢性肾脏疾病和出血风险之间的相关性分析！, objectType=article, longId=119916, objectId=fffe1199168f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fffe1199168f, replyNumber=0, likeNumber=56, createdTime=2017-11-17, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fffe1199168f, moduleTitle=J Thromb Haemost：心血管疾病高风险患者慢性肾脏疾病和出血风险之间的相关性分析！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fffe1199168f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862010, encodeId=d667186201066, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=Stroke：心血管疾病高风险的2型糖尿病患者Empagliflozin治疗与脑血管事件！, objectType=article, longId=95149, objectId=dcd4951496d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=dcd4951496d, replyNumber=0, likeNumber=61, createdTime=2018-03-24, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=dcd4951496d, moduleTitle=Stroke：心血管疾病高风险的2型糖尿病患者Empagliflozin治疗与脑血管事件！, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=dcd4951496d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862015, encodeId=00261862015c5, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=Gastroenterology：隐性恶性粘膜下浸润癌高风险因素, objectType=article, longId=100753, objectId=920c100e5325, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=920c100e5325, replyNumber=0, likeNumber=71, createdTime=2017-07-12, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=920c100e5325, moduleTitle=Gastroenterology：隐性恶性粘膜下浸润癌高风险因素, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=920c100e5325)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862036, encodeId=12b71862036bb, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=Eur Urol：比较醋酸阿比特龙和多西他赛联合雄激素剥夺治疗在高风险和转移性未经激素治疗的前列腺癌中的作用：系统评价与荟萃分析。, objectType=article, longId=116259, objectId=4d8911625997, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4d8911625997, replyNumber=0, likeNumber=87, createdTime=2018-09-08, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4d8911625997, moduleTitle=Eur Urol：比较醋酸阿比特龙和多西他赛联合雄激素剥夺治疗在高风险和转移性未经激素治疗的前列腺癌中的作用：系统评价与荟萃分析。, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=4d8911625997)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862033, encodeId=1e281862033bf, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=SCI REP：在高风险自闭症婴儿中预测非典型发育, objectType=article, longId=112807, objectId=ef4a11280e6a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ef4a11280e6a, replyNumber=0, likeNumber=64, createdTime=2017-09-24, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ef4a11280e6a, moduleTitle=SCI REP：在高风险自闭症婴儿中预测非典型发育, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ef4a11280e6a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862032, encodeId=20681862032e1, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=JAMA Surg：高风险血管手术后心肌梗死风险研究, objectType=article, longId=112278, objectId=52ae1122e865, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=52ae1122e865, replyNumber=0, likeNumber=74, createdTime=2018-06-16, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=52ae1122e865, moduleTitle=JAMA Surg：高风险血管手术后心肌梗死风险研究, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=52ae1122e865)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862038, encodeId=6e671862038a0, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=NCCN临床实践指南：遗传/家族高风险评估-结直肠癌（2017.V3）, objectType=article, longId=117003, objectId=cfd911e00321, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=cfd911e00321, replyNumber=0, likeNumber=31, createdTime=2018-05-09, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=cfd911e00321, moduleTitle=NCCN临床实践指南：遗传/家族高风险评估-结直肠癌（2017.V3）, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=cfd911e00321)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862041, encodeId=7f7f186204160, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=Prostate：高风险前列腺癌病人在首发症状时的预后参数分析, objectType=article, longId=120073, objectId=d0b31200e3df, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d0b31200e3df, replyNumber=0, likeNumber=74, createdTime=2018-01-07, rootId=0, userName=heli0118, userId=21015, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d0b31200e3df, moduleTitle=Prostate：高风险前列腺癌病人在首发症状时的预后参数分析, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d0b31200e3df)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1862021, encodeId=a4be1862021b5, content=<a href='/topic/show?id=a374102813a1' target=_blank style='color:#2F92EE;'>#高风险#</a>, objectTitle=Int J Gynecol Cancer：对早期高风险子宫内膜癌患者放疗时行新辅助化疗的疗效, objectType=article, longId=104325, objectId=da8110432588, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=da8110432588, replyNumber=0, likeNumber=61, createdTime=2018-02-13, rootId=0, userName=zlawrance, userId=f5e185, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=da8110432588, moduleTitle=Int J Gynecol Cancer：对早期高风险子宫内膜癌患者放疗时行新辅助化疗的疗效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=da8110432588)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

高风险

2020-05-29

zlawrance (审核中...)

前往app查看评论内容

#高风险#

Circulation：CD16依赖性自然杀伤细胞活化的遗传学和功能性分析可以识别心脏同种异体移植物脉管病的高风险患者

2017-11-06

zlawrance (审核中...)

前往app查看评论内容

#高风险#

SCI REP：ADAMTS-7与人类动脉粥样硬化中的高风险斑块表型有关

2018-02-27

zlawrance (审核中...)

前往app查看评论内容

#高风险#

Int J Clin Oncol：根治性前列腺切除术后接受新辅助化学激素疗法高风险前列腺癌病人的总生存率研究

2018-06-24

zlawrance (审核中...)

前往app查看评论内容

#高风险#

J Diabetes Complications：2型糖尿病患者中，高丙氨酸氨基转移酶水平患者的临床表型与高风险的NAFLD纤维化评分患者的临床表型不同

2018-10-12

zlawrance (审核中...)

前往app查看评论内容

#高风险#

Eur Uro：中/高风险局限性前列腺癌最终治疗的种族差异：设施特征和社会经济特征的影响。

2018-01-16

zlawrance (审核中...)

前往app查看评论内容

#高风险#

CLIN CANCER RES ：miRNA-DNMT1轴与与阿扎胞苷抵抗及预测高风险骨髓增生异常综合征和低原始细胞急性髓系白血病预后有关

2017-09-17

zlawrance (审核中...)

前往app查看评论内容

#高风险#

JAMA：钠尿肽指导治疗策略对心衰高风险患者的临床意义

2018-04-26

zlawrance (审核中...)

前往app查看评论内容

#高风险#

JAMA N：卒中二级预防，吡格列酮对高风险者更加有效

2018-04-30

zlawrance (审核中...)

前往app查看评论内容

#高风险#

Eur Heart J：多学科讨论：ACC/AHA极高风险标准分辨心血管病复发的能力如何？

2018-07-06

zlawrance (审核中...)

前往app查看评论内容

#高风险#

ANN ONCOL：10年随访结果表明高风险原发乳腺癌患者接受剂量密集化疗生存情况优于常规化疗

2018-08-12

zlawrance (审核中...)

前往app查看评论内容

#高风险#

CLIN CANCER RES：依鲁替尼联合利妥昔单抗治疗高风险慢性淋巴细胞性白血病

2017-08-07

zlawrance (审核中...)

前往app查看评论内容

#高风险#

J Thromb Haemost：心血管疾病高风险患者慢性肾脏疾病和出血风险之间的相关性分析！

2017-11-17

zlawrance (审核中...)

前往app查看评论内容

#高风险#

Stroke：心血管疾病高风险的2型糖尿病患者Empagliflozin治疗与脑血管事件！

2018-03-24

zlawrance (审核中...)

前往app查看评论内容

#高风险#

Gastroenterology：隐性恶性粘膜下浸润癌高风险因素

2017-07-12

zlawrance (审核中...)

前往app查看评论内容

#高风险#

Eur Urol：比较醋酸阿比特龙和多西他赛联合雄激素剥夺治疗在高风险和转移性未经激素治疗的前列腺癌中的作用：系统评价与荟萃分析。

2018-09-08

zlawrance (审核中...)

前往app查看评论内容

#高风险#

SCI REP：在高风险自闭症婴儿中预测非典型发育

2017-09-24

zlawrance (审核中...)

前往app查看评论内容

#高风险#

JAMA Surg：高风险血管手术后心肌梗死风险研究

2018-06-16

zlawrance (审核中...)

前往app查看评论内容

#高风险#

NCCN临床实践指南：遗传/家族高风险评估-结直肠癌（2017.V3）

2018-05-09

heli0118 (审核中...)

前往app查看评论内容

#高风险#

Prostate：高风险前列腺癌病人在首发症状时的预后参数分析

2018-01-07

zlawrance (审核中...)

前往app查看评论内容

#高风险#

Int J Gynecol Cancer：对早期高风险子宫内膜癌患者放疗时行新辅助化疗的疗效

2018-02-13

科室
- - 订阅+
  - 更多科室
工具
服务